<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F1D48D3B-EDD2-4C7D-9CCE-AA1FF1D31747"><gtr:id>F1D48D3B-EDD2-4C7D-9CCE-AA1FF1D31747</gtr:id><gtr:name>ICSTM at Hammersmith</gtr:name><gtr:address><gtr:line1>Imperial College of Sci, Tech and Med</gtr:line1><gtr:line2>ICSTM at Hammersmith Hospital</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:postCode>W12  ONN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2A0215D6-79D1-435B-A1EB-6FE0BE3713FA"><gtr:id>2A0215D6-79D1-435B-A1EB-6FE0BE3713FA</gtr:id><gtr:firstName>Ben</gtr:firstName><gtr:surname>Wakerley</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501747"><gtr:id>8637D091-6B47-4F5A-9D41-D539B4E7E205</gtr:id><gtr:title>Molecular and Functional Analysis of the relationship between T cell Myelin Epitopes and Disease in Multiple Sclerosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501747</gtr:grantReference><gtr:abstractText>Multiple Sclerosis is an inflammatory disease of the nervous system characterised by damage to myelin which coats the nerves. Through an abnormal immune response, white blood cells (T-cells), attack myelin fragments (?epitopes?). Treatments are being sought that specifically block this immune response. The approach assumes a detailed understanding of the immune response underlying MS - in fact, that information is patchy. Designing experiments to prove whether or not a particular immune response measured in the test tube is responsible for a patient?s MS is challenging. This project will study the immune response in MS patients at different stages of their disease, aiming to answer the questions: i) Do patients with newly diagnosed MS have T-cells recognizing different myelin epitopes compared to long-term patients? and ii) Can the functional role of these cells in the disease process be pinned down, in terms of the inflammatory chemicals they make (cytokines) and by looking for evidence that they were strongly stimulated while they were in the blood of the patient during the disease process in studies of ?telomere length? - the idea that long lived immunologically active cells can be identified by looking at the length of their eroded chromosomes</gtr:abstractText><gtr:technicalSummary>BACKGROUND - Multiples Sclerosis is a disease of the CNS in which inflammation causes damage to the myelin sheath leading to axonal degeneration. A common view is that the inflammatory damage results from autoimmune attack of myelin epitopes by self-reactive T lymphocytes. Many current hopes for treatment of MS rest on specific immunotherapeutics, capable of blocking the autoimmune response without global immunosuppression. However, this rationale assumes a clear understanding of the specific autoimmune responses responsible for the disease. While an enormous amount of data has previously been generated on T lymphocyte immune responses during MS, the causal relationship between these rather heterogeneous myelin responses and pathogenesis is unclear. In murine experimental models, important information about this has come from analysis of epitope spread during disease. AIMS AND OBJECTIVES - The proposed study will examine the difference between myelin-specific immune responses of patients at different stages of disease. This will allow the investigation of a number of specific issues pertinent to pathogenesis. Firstly, it will allow the acquisition of data in a case-controlled, retrospective, cross-sectional study of patient groups at different time points from diagnosis. The host laboratory previously reported a preliminary study of this type, though without functional data. Data from this training fellowship will, in the first instance, test the notion that the disease process is associated with spread of the T cell response through different myelin epitopes. This will be further investigated with respect to any differences in oligoclonality of T cell responses and patterns of cytokine responsiveness. A key goal of the study will be to correlate functional T cell responses with telomere length, as a means of drawing inferences about the replicative history of these T cell populations with respect to chronic antigen stimulation in vivo during the disease. DESIGN AND METHODOLOGY - Peripheral blood samples from MS patients with disease of short or long duration will be obtained from patients attending Charing Cross Hospital. Functional information on T cell responses to myelin epitopes will come from T cell proliferation assays, T cell receptor DNA sequence analysis, real-time qPCR, cytokine ELIspot analysis and, importantly, from flow cytometric analysis relating cytokine responses to telomere length. SCIENTIFIC AND MEDICAL OPPORTUNITIES - This will allow a more detailed appraisal of the functional relationship between specific autoimmune T cell responses and MS pathogenesis, paving the way for more specific therapies.</gtr:technicalSummary><gtr:fund><gtr:end>2009-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>194582</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CD397118-5747-4547-865A-696D34CE45AB</gtr:id><gtr:title>Posterior reversible encephalopathy syndrome complicating diabetic ketoacidosis; an important treatable complication.</gtr:title><gtr:parentPublicationTitle>Pediatric diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80b6fa8bab35a059b42c83d6782298a1"><gtr:id>80b6fa8bab35a059b42c83d6782298a1</gtr:id><gtr:otherNames>Jones R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1399-543X</gtr:issn><gtr:outcomeId>56cb251fbe6fd3.28149834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19DC1130-8EE5-4F87-AA50-4A3877CDA36A</gtr:id><gtr:title>MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity.</gtr:title><gtr:parentPublicationTitle>BMC neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abaf7311bf4d567d6cc6fec919fe1c92"><gtr:id>abaf7311bf4d567d6cc6fec919fe1c92</gtr:id><gtr:otherNames>Nicholas RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2377</gtr:issn><gtr:outcomeId>5675e3acf1f02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>173B336B-2A6B-4D3E-9AF8-17BA012EA1B6</gtr:id><gtr:title>Multiple sclerosis</gtr:title><gtr:parentPublicationTitle>Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7dc7f8ade49de22ee7891763ccbb22c3"><gtr:id>7dc7f8ade49de22ee7891763ccbb22c3</gtr:id><gtr:otherNames>Wakerley B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>iM59Ks6mmyS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E132F92-D39C-4954-9961-A628177CC4AD</gtr:id><gtr:title>Multiple sclerosis in Japan appears to be a milder disease compared to the UK.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dec6071aaad9eb454b7f6ea9f72c5cc"><gtr:id>3dec6071aaad9eb454b7f6ea9f72c5cc</gtr:id><gtr:otherNames>Piccolo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56cb2520c18196.76283199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5820FCC1-6E75-4F95-AF1A-728C2F44DAE4</gtr:id><gtr:title>Guillain-Barr&amp;eacute; syndrome.</gtr:title><gtr:parentPublicationTitle>Expert review of neurotherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-7175</gtr:issn><gtr:outcomeId>56cb24cab064a6.26773259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0700F1F5-4315-4FA8-AF8C-72F2F1343B00</gtr:id><gtr:title>Vascular contribution to hyperglycaemia-induced hemichorea.</gtr:title><gtr:parentPublicationTitle>Diabetes &amp; vascular disease research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/010aed5b23046b29c6b8fe7524db8976"><gtr:id>010aed5b23046b29c6b8fe7524db8976</gtr:id><gtr:otherNames>Ahmad A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1479-1641</gtr:issn><gtr:outcomeId>pm_13990_20_23288879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64F7225B-8AAE-4EA9-BFD5-190B18613CFC</gtr:id><gtr:title>Extracorporeal membrane oxygenation-related brain haemorrhages.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3af618e73c86a0a3c530a53fad4efeb9"><gtr:id>3af618e73c86a0a3c530a53fad4efeb9</gtr:id><gtr:otherNames>Witherick J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>56cb251fe7c503.18438825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE1C353B-0EA3-422A-AD10-620F41A3A388</gtr:id><gtr:title>Red ear syndrome: a review of all published cases (1996-2010).</gtr:title><gtr:parentPublicationTitle>Cephalalgia : an international journal of headache</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cbdbc75db97d0a1f999dc72fa7d8586"><gtr:id>4cbdbc75db97d0a1f999dc72fa7d8586</gtr:id><gtr:otherNames>Ryan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0333-1024</gtr:issn><gtr:outcomeId>pm_13990_20_23207115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7C174E7-AB5A-4F1A-BA27-EB87EFA53BFA</gtr:id><gtr:title>Paraparetic Guillain-Barr&amp;eacute; syndrome: Nondemyelinating reversible conduction failure restricted to the lower limbs.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab447e5ae1115adac989315069780661"><gtr:id>ab447e5ae1115adac989315069780661</gtr:id><gtr:otherNames>Kimachi T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>589979286f0488.11970321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E21DC9D5-0986-431B-9271-0AD6809B56AB</gtr:id><gtr:title>Anti-TNF-a therapy itself does not trigger Guillain-Barr&amp;eacute; syndrome.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0392-856X</gtr:issn><gtr:outcomeId>pm_13990_20_23557994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A04ECCF-4C09-452F-BCC7-89BD1A721ACE</gtr:id><gtr:title>Monitoring intravenous immunoglobulin dosing regimens in chronic inflammatory demyelinating polyneuropathy: search for a biomarker.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_13990_20_23606735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D27D759-D45A-408B-93E4-D1B706ED22CB</gtr:id><gtr:title>Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_13990_20_23804237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C07F1DA-6DEF-43F6-80AE-4F73D257B9DF</gtr:id><gtr:title>Stumbling towards a diagnosis.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>56cb24ca197d45.04492817</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DB59F38-3FE3-4BAF-A1E9-254868918285</gtr:id><gtr:title>Reply.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab447e5ae1115adac989315069780661"><gtr:id>ab447e5ae1115adac989315069780661</gtr:id><gtr:otherNames>Kimachi T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>58997929078010.38052251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85AE8D4D-8E25-4834-A8F0-C4AF40D49654</gtr:id><gtr:title>Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_13990_20_23564757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A48F4C3-9140-429C-9A31-E69B94BD9AEA</gtr:id><gtr:title>Progressive dysphagia without dysarthria.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>pm_13990_20_23487809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D861405B-210E-4F6B-84D5-C6B301EDB03B</gtr:id><gtr:title>Guillain-Barr&amp;eacute; syndrome in general practice: clinical features suggestive of early diagnosis.</gtr:title><gtr:parentPublicationTitle>The British journal of general practice : the journal of the Royal College of General Practitioners</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1860894c727119b95942488416a96ae9"><gtr:id>1860894c727119b95942488416a96ae9</gtr:id><gtr:otherNames>Head VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-1643</gtr:issn><gtr:outcomeId>589979289849f7.70424149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B9CE534-65F2-4777-A1EF-B03133CF7B84</gtr:id><gtr:title>Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f12a5243fbec538aca50fcd9d993bf45"><gtr:id>f12a5243fbec538aca50fcd9d993bf45</gtr:id><gtr:otherNames>Yeo LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_13990_20_23599933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7452FA4-0175-4C28-87AA-D116F1F11D7D</gtr:id><gtr:title>Infectious and noninfectious triggers in Guillain-Barr&amp;eacute; syndrome.</gtr:title><gtr:parentPublicationTitle>Expert review of clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1744-666X</gtr:issn><gtr:outcomeId>pm_13990_20_23899233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0718979-A35D-4244-80D6-952748B0E61B</gtr:id><gtr:title>Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barr&amp;eacute; syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56cb24ca7897e6.43344659</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D758F14C-729C-45A0-B849-BE464BC691D1</gtr:id><gtr:title>Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.</gtr:title><gtr:parentPublicationTitle>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f12a5243fbec538aca50fcd9d993bf45"><gtr:id>f12a5243fbec538aca50fcd9d993bf45</gtr:id><gtr:otherNames>Yeo LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1052-3057</gtr:issn><gtr:outcomeId>pm_13990_20_23954601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3CE6B29-F1BD-4A0B-BAB0-2E141C7F0870</gtr:id><gtr:title>Transcranial Doppler sonography in patients with severe brain injury.</gtr:title><gtr:parentPublicationTitle>Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0278-4297</gtr:issn><gtr:outcomeId>56cb24cb189434.82735583</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90D5FAF3-CBB7-4AC3-9BE9-933886DD530D</gtr:id><gtr:title>External validation of the Boston Acute Stroke Imaging Scale and M1-BASIS in thrombolyzed patients.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f12a5243fbec538aca50fcd9d993bf45"><gtr:id>f12a5243fbec538aca50fcd9d993bf45</gtr:id><gtr:otherNames>Yeo LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>56cb2520ed6614.63035577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B003F6F5-5FF4-4EDD-939A-2D8E8579069C</gtr:id><gtr:title>Peripheral neuropathies: Subcutaneous immunoglobulin - the future of CIDP treatment?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>5aaa4f2e3ac858.72800096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>154DA7C7-1EB8-46EE-B7E0-E2070EFBA607</gtr:id><gtr:title>Acute peripheral weakness and suspected Guillain-Barr&amp;eacute; syndrome.</gtr:title><gtr:parentPublicationTitle>British journal of hospital medicine (London, England : 2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b4773962720abd17428f4df1f3245e3"><gtr:id>1b4773962720abd17428f4df1f3245e3</gtr:id><gtr:otherNames>Morgan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-8460</gtr:issn><gtr:outcomeId>56cb25201c8ad1.19996124</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F168C7EE-E711-4515-9931-AC0190F1A675</gtr:id><gtr:title>Letter 2.</gtr:title><gtr:parentPublicationTitle>Journal of travel medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1195-1982</gtr:issn><gtr:outcomeId>56cb24cbcb42f0.63869925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F89FBF83-0225-42E8-93B1-65304191FF33</gtr:id><gtr:title>Surgery itself does not trigger Guillain-Barr&amp;eacute; syndrome.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>pm_13990_20_23406451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>248A7228-8DEE-4573-AFD3-C583C89A7B75</gtr:id><gtr:title>Guillain-Barr&amp;eacute; and Miller Fisher syndromes--new diagnostic classification.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>56cb24cb9fa8e5.71993758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99A222D7-132D-44C9-BC3F-C265DC3C0E06</gtr:id><gtr:title>Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/809b4086fcbd8d5c1c06308f735111f0"><gtr:id>809b4086fcbd8d5c1c06308f735111f0</gtr:id><gtr:otherNames>Mok T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>58997928c20560.27628719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F29FEC8-7396-48E1-923C-805345F81764</gtr:id><gtr:title>Usefulness of transcranial Doppler-derived cerebral hemodynamic parameters in the noninvasive assessment of intracranial pressure.</gtr:title><gtr:parentPublicationTitle>Journal of neuroimaging : official journal of the American Society of Neuroimaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1051-2284</gtr:issn><gtr:outcomeId>56cb24cade84e3.86141198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D71B7BD-3CC0-4C4C-9532-55FA6CFCDCAA</gtr:id><gtr:title>Early electroencephalography in patients with Emergency Room diagnoses of suspected new-onset seizures: Diagnostic yield and impact on clinical decision-making.</gtr:title><gtr:parentPublicationTitle>Seizure</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ed3746e0986ced75c1e97332d4db6da"><gtr:id>6ed3746e0986ced75c1e97332d4db6da</gtr:id><gtr:otherNames>Paliwal P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1059-1311</gtr:issn><gtr:outcomeId>56cb25204ae985.75362005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>354AF9AD-E0A2-47D7-9311-673CF631B63A</gtr:id><gtr:title>Bifacial weakness with paresthesias: Serial nerve conduction studies indicate diffuse demyelinating neuropathy.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b4773962720abd17428f4df1f3245e3"><gtr:id>1b4773962720abd17428f4df1f3245e3</gtr:id><gtr:otherNames>Morgan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>56cb251f929182.17621458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00DF60BD-138F-4109-AA9E-A09400216B98</gtr:id><gtr:title>Atypical Bickerstaff brainstem encephalitis: pitfalls of diagnosis.</gtr:title><gtr:parentPublicationTitle>Pediatric neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0887-8994</gtr:issn><gtr:outcomeId>pm_13990_20_23953997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D623EEB-DE4B-4197-903C-B4352D72D4D9</gtr:id><gtr:title>Overlap of acute mydriasis and acute pharyngeal weakness associated with anti-GQ1b antibodies.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>5aaa4f2e6e10c9.10497051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53465658-3587-4BF7-AB3D-A96D75B31B07</gtr:id><gtr:title>Non-invasive intracranial pressure monitoring with transcranial Doppler in a patient with progressive cerebral venous sinus thrombosis.</gtr:title><gtr:parentPublicationTitle>Journal of neuroimaging : official journal of the American Society of Neuroimaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7dc7f8ade49de22ee7891763ccbb22c3"><gtr:id>7dc7f8ade49de22ee7891763ccbb22c3</gtr:id><gtr:otherNames>Wakerley B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1051-2284</gtr:issn><gtr:outcomeId>pm_13990_20_23228062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3F59EF4-AF69-40E8-A5F8-3F7A68200120</gtr:id><gtr:title>Polyneuritis cranialis--subtype of Guillain-Barr&amp;eacute; syndrome?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>56cb24ca4777a4.64958953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>167FA815-AFE2-402D-926B-C714105FDB62</gtr:id><gtr:title>Mimics and chameleons in Guillain-Barr&amp;eacute; and Miller Fisher syndromes.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>56cb24cb40ac60.78633591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D749CA5-77D0-43E2-AFC7-80933B06A7CF</gtr:id><gtr:title>Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases.</gtr:title><gtr:parentPublicationTitle>Expert review of neurotherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2fe95584d171fef79da2abac088c499"><gtr:id>b2fe95584d171fef79da2abac088c499</gtr:id><gtr:otherNames>Pilch KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-7175</gtr:issn><gtr:outcomeId>58997928e1eea6.51578617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9ADEFCFD-EA8F-462D-A01B-1A65BD00040A</gtr:id><gtr:title>Isolated facial diplegia in Guillain-Barr&amp;eacute; syndrome: Bifacial weakness with paresthesias.</gtr:title><gtr:parentPublicationTitle>Muscle &amp; nerve</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0148-639X</gtr:issn><gtr:outcomeId>56cb24c9d368f8.45333474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF7150CD-29A8-4BEB-BAB2-993A246EFE4F</gtr:id><gtr:title>Assessment of intracranial collaterals on CT angiography in anterior circulation acute ischemic stroke.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f12a5243fbec538aca50fcd9d993bf45"><gtr:id>f12a5243fbec538aca50fcd9d993bf45</gtr:id><gtr:otherNames>Yeo LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>56cb2520880259.09591634</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B95A3A72-6ADA-47BA-B236-0DA209650657</gtr:id><gtr:title>Idiopathic intracranial hypertension.</gtr:title><gtr:parentPublicationTitle>Cephalalgia : an international journal of headache</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0333-1024</gtr:issn><gtr:outcomeId>56cb24cb6887d9.87511733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99C0557E-DD0E-4947-9BF3-8DE7A8E9B76B</gtr:id><gtr:title>Impaired cognition and hemispatial neglect in a woman with neck pain. Carcinomatous meningoencephalitis.</gtr:title><gtr:parentPublicationTitle>Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b2b5a25623eebfaee8f1247a7949af"><gtr:id>44b2b5a25623eebfaee8f1247a7949af</gtr:id><gtr:otherNames>Wakerley BR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0967-5868</gtr:issn><gtr:outcomeId>pm_13990_20_23431566</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501747</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>